| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $321K | — |
| Cost of Revenue | $248K | — |
| Gross Profit | $72K | — |
| R&D Expense | $337K | +160.6% |
| SG&A Expense | $492K | +277.7% |
| Operating Income | -$1.2M | -186.1% |
| Interest Expense | $237K | -74.2% |
| Pre-tax Income | -$1.5M | +61.1% |
| Net Income | -$1.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $12K | — |
| Inventory | $1.1M | — |
| Current Assets | $2.9M | -14.0% |
| Total Assets | $3.4M | -3.9% |
| Current Liabilities | $474K | -46.1% |
| Long-term Debt | $271K | -7.4% |
| Total Liabilities | $652K | -25.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | -538.3% |
| Capital Expenditures | $122K | +81.8% |
| Investing Cash Flow | -$122K | -81.8% |
| Financing Cash Flow | $815K | -77.9% |
| Free Cash Flow | -$2.4M | -464.7% |
| +61.1% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Stockholders' Equity |
| $2.7M |
| +3.4% |